Dionymer, a French biotechnology company, secured €7 million in Seed funding to advance its development of biodegradable polymers derived from organic waste, positioning itself as a leader in the sustainable materials industry.
Target Information
Dionymer is a French industrial biotechnology company focused on developing biodegradable polymer materials derived from organic waste. The company recently announced a successful Seed funding round of €7 million, which received investment from UI Investissement, BNP Paribas Développement, BPI France (French Tech Seed), NACO (M Capital), and its historical investors IRDI, Aquiti, AFI Ventures, and Resiliance, all of whom showed renewed confidence in the venture.
Dionymer specializes in the production of PolyHydroxyAlcanoates (PHA), which are available in both powder and granule forms. These circular materials have demonstrated optimal performance and serve as a virtuous industrial alternative to polluting petrochemical polymers. The company aims to provide solutions that meet the transition challenges faced by the cosmetics, plastics, coatings, and textile sectors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The biotechnology industry in France is flourishing, driven primarily by innovative startups like Dionymer that focus on sustainability and circular economy principles. With an increasing awareness of environmen
Similar Deals
Bpifrance Amorçage Industriel, BNP Paribas Développement, private investors, banking partners → OSTREA
2025
Business Angels des Grandes Ecoles (BADGE) → AITHRA
2025
UI Investissement, BNP Paribas Développement, BPI France, NACO, IRDI, Aquiti, AFI Ventures, Resiliance
invested in
Dionymer
in 2026
in a Seed Stage deal
Disclosed details
Transaction Size: $7M